5 Best NASDAQ Stocks Under $20

4. Roivant Sciences Ltd. (NASDAQ:ROIV)

Number of Hedge Fund Investors In Q1 2023: 43

Roivant Sciences Ltd. (NASDAQ:ROIV) is a biotechnology company that develops treatments for immune system disorders. The firm has several impressive treatments in its portfolio, such as the one for dermatitis which demonstrated positive results in a Phase 3 trial.

Insider Monkey dug through 943 hedge funds for this year’s first quarter to find out that 43 had invested in the firm. Out of these, Roivant Sciences Ltd. (NASDAQ:ROIV)’s largest shareholder is Daniel Gold’s QVT Financial courtesy of an investment worth $904 million.

Follow Roivant Sciences Ltd.